CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clinical trial NCT00112840 · COMPLETED

Trial details

NCT number: NCT00112840
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2005-05-01
Primary completion: 2010-08-09
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.